One patient participated in the study twice: this patient successfully completed the study but, approximately 11 weeks after rilonacept discontinuation, developed a pericarditis recurrence (pain NRS 7/10; CRP 23.1 mg/dL) and cardiac tamponade requiring pericardiocentesis. The gene discussed is CRP; the disease is cardiac tamponade.